Drug intelligence / Profile preview

DynaGraft II Dental

Development stage
Unknown
Lead developer
IsoTis
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Implant
01

Overview

DynaGraft II Dental is a bone graft substitute medical device composed of demineralized bone matrix (DBM) derived from donated human bone tissue. Developed by IsoTis OrthoBiologics (now part of Integra LifeSciences), it is specifically formulated for dental applications such as filling bone voids and promoting regeneration in periodontal or alveolar defects. The product utilizes a unique poloxamer-based reverse phase carrier, which allows the material to be malleable at room temperature and become more viscous at body temperature, thereby minimizing migration from the operative site. The DBM component provides an osteoinductive scaffold containing naturally occurring growth factors, such as bone morphogenetic proteins (BMPs), that promote bone repair and regeneration. It is available in gel and putty consistencies and received FDA 510(k) clearance in 2005.

Brand names
DynaGraft II Dental
Other names
DynaGraft II
02

Targets

BMP (Bone morphogenetic protein family)

Beyond the preview

Go deeper on DynaGraft II Dental.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DynaGraft II Dental.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call